Bridgeway Capital Management, LLC Sio Gene Therapies Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.28 - $0.44 $25,144 - $39,512	-89,800 Reduced 85.2%	15,600 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.28 - $0.41 $14,000 - $20,500	-50,000 Reduced 32.18%	105,400 $30,000
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $22,375 - $65,335	-89,500 Reduced 36.55%	155,400 $56,000
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $55,000 - $147,000	-100,000 Reduced 28.99%	244,900 $164,000
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $89,010 - $162,840	-69,000 Reduced 16.67%	344,900 $445,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $209,236 - $312,120	115,600 Added 38.75%	413,900 $898,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $41,400 - $57,800	-20,000 Reduced 6.28%	298,300 $814,000
Q1 2021 May 17, 2021	BUY	$2.34 - $3.44 $744,822 - $1.09 Million	318,300 New	318,300 $831,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.